Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 833 to 882 of 3228 in total
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    \def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 833\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PSIP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent pc4 and sfrs1 interacting protein 2; pc4 and sfrs1 interacting protein 1; transcriptional coactivator p52/p75. [source:refseq;acc:nm\_033222]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 231.734\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 222.222\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0428\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RPL8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 60s ribosomal protein l8. [source:swissprot;acc:p25120]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 835\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HDGF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent hepatoma-derived growth factor (hdgf) (high-mobility group protein 1- like 2) (hmg-1l2). [source:swissprot;acc:p51858]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 836\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HDGFL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent pwwp domain containing 1; hdgf (hepatoma-derived growth factor) like. [source:refseq;acc:nm\_138574]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 837\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DDX6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent probable atp-dependent rna helicase p54 (oncogene rck) (dead-box protein 6). [source:swissprot;acc:p26196]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 838\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TMEM131\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent rw1 protein (fragment). [source:swissprot;acc:q92545]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 839\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CLEC11A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent stem cell growth factor; lymphocyte secreted c-type lectin; lymphocyte secreted c-type lectin. [source:refseq;acc:nm\_002975]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 177.776\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 170.499\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04268\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 840\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TOMM20\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent mitochondrial import receptor subunit tom20 homolog (mitochondrial 20 kda outer membrane protein) (outer mitochondrial membrane receptor tom20). [source:swissprot;acc:q15388]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 198.781\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 190.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04259\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 841\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PEX19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent peroxisomal farnesylated protein (33 kda housekeeping protein) (peroxin 19). [source:swissprot;acc:p40855]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 842\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CCDC22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent jm1 protein. [source:refseq;acc:nm\_014008]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 210.806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04248\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 843\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GART\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent trifunctional purine biosynthetic protein adenosine-3 [includes: phosphoribosylamine--glycine ligase (ec 6.3.4.13) (gars) (glycinamide ribonucleotide synthetase) (phosphoribosylglycinamide synthetase); phosphoribosylformylglycinamidine cyclo-ligase (ec 6.3.3.1) (airs) (phosphoribosyl-aminoimidazole synthetase) (air synthase); phosphoribosylglycinamide formyltransferase (ec 2.1.2.2) (gart) (gar transformylase) (5'-phosphoribosylglycinamide transformylase)]. [source:swissprot;acc:p22102]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.521\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 227.796\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04244\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CLEC3A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 178.033\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 170.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04223\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 845\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent LSM1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent u6 snrna-associated sm-like protein lsm1 (small nuclear ribonuclear casm) (cancer-associated sm-like). [source:swissprot;acc:o15116]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.599\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04193\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent methyltransferase like 2. [source:refseq;acc:nm\_018396]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 147.211\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 153.371\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04184\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 847\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DYNLT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cytoplasmic dynein light chain (t-complex testis-specific protein 1 homolog) (protein cw-1). [source:swissprot;acc:q15763]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 848\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FZR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent fzr1 protein; fizzy-related protein; cdc20-like 1b. [source:refseq;acc:nm\_016263]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 849\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PCSK5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proprotein convertase subtilisin/kexin type 5 precursor (ec 3.4.21.-) (proprotein convertase pc5) (subtilisin/kexin-like protease pc5) (convertase pc5) (pc6) (hpc6). [source:swissprot;acc:q92824]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 850\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CPSF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cleavage and polyadenylation specific factor 4, 30kd subunit; cleavage-polyadenylation specificity factor, 30kd; no arches-like (zebrafish) zinc finger protein; cleavage-polyadenylation specificity factor. [source:refseq;acc:nm\_006693]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 107.842\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 112.329\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04161\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 851\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent KIAA1012\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent trs85 homolog. [source:swissprot;acc:q9y2l5]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HPRT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) (hgprt) (hgprtase). [source:swissprot;acc:p00492]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 193.114\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 185.412\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04154\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 853\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent WDR33\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent wd-repeat protein wdc146. [source:swissprot;acc:q9c0j8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 108.289\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 112.772\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0414\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 854\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CPSF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cleavage and polyadenylation specificity factor, 160 kda subunit (cpsf 160 kda subunit). [source:swissprot;acc:q10570]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CLEC3B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tetranectin precursor (tn) (plasminogen-kringle 4 binding protein). [source:swissprot;acc:p05452]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 178.514\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 171.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04138\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent XPR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent xenotropic and polytropic retrovirus receptor. [source:refseq;acc:nm\_004736]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.028\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 206.623\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04068\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PNO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent putatative 28 kda protein. [source:refseq;acc:nm\_020143]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 236.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.0406\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent STX12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent syntaxin 12. [source:refseq;acc:nm\_177424]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.997\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.04043\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 859\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent 60s ribosomal protein l39. [source:swissprot;acc:p02404]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 234.025\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 224.958\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.04031\vspace{3pt}}}\\\cline{1-1}\cline{3-3} \parbox{\wcA}{\vspace{3pt}\noindent 860\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 60s ribosomal protein l18a. [source:swissprot;acc:q02543]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RPS19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 40s ribosomal protein s19. [source:swissprot;acc:p39019]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RPL31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 60s ribosomal protein l31. [source:swissprot;acc:p12947]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 863\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CSNK2A1P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent casein kinase ii, alpha chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19138]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 240.194\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 230.957\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03999\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 864\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CSNK2A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent casein kinase ii, alpha' chain (ck ii) (ec 2.7.1.37). [source:swissprot;acc:p19784]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent BTF3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent transcription factor btf3 (rna polymerase b transcription factor 3). [source:swissprot;acc:p20290]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.961\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.814\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03997\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 866\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SRP68\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent signal recognition particle 68 kda protein (srp68). [source:swissprot;acc:q9uhb9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.306\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03994\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 867\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 40s ribosomal protein s3a. [source:swissprot;acc:p49241]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.689\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.674\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03981\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 868\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MVD\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent diphosphomevalonate decarboxylase (ec 4.1.1.33) (mevalonate pyrophosphate decarboxylase) (mevalonate (diphospho)decarboxylase). [source:swissprot;acc:p53602]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 233.298\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 242.571\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03975\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 869\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent EXOC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent exocyst complex component sec8. [source:swissprot;acc:q96a65]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.762\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 209.449\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03969\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 870\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent transcription factor btf3 homolog 3. [source:swissprot;acc:q13892]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.908\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 203.832\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03962\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 871\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CPSF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cleavage and polyadenylation specificity factor, 100 kda subunit (cpsf 100 kda subunit) (fragment). [source:swissprot;acc:q9p2i0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 110.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 114.552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03949\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 872\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HNRPK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein k (hnrnp k) (dc-stretch binding protein) (csbp) (transformation upregulated nuclear protein) (tunp). [source:swissprot;acc:q07244]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 224.413\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 233.272\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03948\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 873\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRPF4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent u4/u6 small nuclear ribonucleoprotein prp4 (u4/u6 snrnp 60 kda protein) (wd splicing factor prp4) (hprp4). [source:swissprot;acc:o43172]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 874\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-1 subunit (ampk gamma-1 chain) (ampkg). [source:swissprot;acc:p54619]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.002\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 203.954\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.03946\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 875\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, catalytic alpha-2 chain (ec 2.7.1.-) (ampk alpha-2 chain). [source:swissprot;acc:p54646]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 876\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, catalytic alpha-1 chain (ec 2.7.1.-) (ampk alpha-1 chain). [source:swissprot;acc:q13131]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 877\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, beta-2 subunit (ampk beta-2 chain). [source:swissprot;acc:o43741]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 878\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-3 subunit (ampk gamma-3 chain) (ampk gamma3). [source:swissprot;acc:q9ugi9]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 879\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, beta-1 subunit (ampk beta-1 chain) (ampkb). [source:swissprot;acc:q9y478]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 880\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5'-amp-activated protein kinase, gamma-2 subunit (ampk gamma-2 chain) (ampk gamma2) (h91620p). [source:swissprot;acc:q9ugj0]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 881\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MYCL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.604\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.001\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03928\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 882\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MYCN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent n-myc proto-oncogene protein. [source:swissprot;acc:p04198]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.008\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.03924\vspace{3pt}}\\\hline nd{longtable}
    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Hugo is the HGNC identifier if it exists
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/